These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 8032190)
1. Imaging of the heart with positron emission tomography. Bergmann SR Am J Card Imaging; 1994 Apr; 8(2):181-8. PubMed ID: 8032190 [No Abstract] [Full Text] [Related]
2. The clinical role of positron emission tomography for cardiology in the 1990s and beyond. Goldstein RA; Willerson JT J Nucl Med; 1991 Apr; 32(4):606-9. PubMed ID: 2013800 [No Abstract] [Full Text] [Related]
3. The clinical role of metabolic imaging of the heart by positron emission tomography. Schwaiger M; Hicks R J Nucl Med; 1991 Apr; 32(4):565-78. PubMed ID: 2013798 [No Abstract] [Full Text] [Related]
4. Application of positron emission tomography in the heart. Council on Scientific Affairs. Report of the Positron Emission Tomography Panel. JAMA; 1988 Apr 22-29; 259(16):2438-45. PubMed ID: 3280846 [TBL] [Abstract][Full Text] [Related]
5. What should we expect from cardiac PET? Garcia EV; Eisner RL; Patterson RE J Nucl Med; 1993 Jun; 34(6):978-80. PubMed ID: 8509868 [No Abstract] [Full Text] [Related]
6. Current and future directions for clinical investigation of the heart with positron-emission tomography. Selwyn AP; Smith TW Circulation; 1985 Nov; 72(5 Pt 2):IV31-8. PubMed ID: 3876892 [No Abstract] [Full Text] [Related]
7. Positron emission tomography in the diagnosis and management of coronary artery disease. Bratton NG J La State Med Soc; 1995 May; 147(5):193-6. PubMed ID: 7782672 [TBL] [Abstract][Full Text] [Related]
8. [Positron computed tomography of the heart]. Yoshida K; Masuda Y; Yamazaki T; Tateno Y Kokyu To Junkan; 1984 Mar; 32(3):241-8. PubMed ID: 6610906 [No Abstract] [Full Text] [Related]
9. [Evaluation of dilated cardiomyopathy and coronary artery disease using positron CT (PCT)]. Fudo T; Kambara H; Hashimoto T; Hayashi M; Kawai C Kokyu To Junkan; 1988 Jun; 36(6):649-53. PubMed ID: 3265217 [No Abstract] [Full Text] [Related]
16. Quantitation of the critically ischemic zone at risk during acute coronary occlusion using PET. Merhige M; Garza D; Sease D; Rowe RW; Tewson T; Emran A; Bolomey L; Gould KL J Nucl Med; 1991 Aug; 32(8):1581-6. PubMed ID: 1869983 [TBL] [Abstract][Full Text] [Related]
17. The expected value of cash flows in the economic analysis of clinical positron emission tomography of the heart. Gleason JM; Frick MP J Nucl Med; 1990 Nov; 31(11):1893-6. PubMed ID: 2121917 [No Abstract] [Full Text] [Related]
18. Positron emission tomography, the best available standard for viable myocardium: a "wealthy" tool for what? Parodi O J Nucl Biol Med (1991); 1992; 36(3):267-72. PubMed ID: 1486120 [No Abstract] [Full Text] [Related]
19. Noninvasive assessment of myocardial perfusion and metabolism: feasibility of registering gated MR and PET images. Sinha S; Sinha U; Czernin J; Porenta G; Schelbert HR AJR Am J Roentgenol; 1995 Feb; 164(2):301-7. PubMed ID: 7839959 [TBL] [Abstract][Full Text] [Related]
20. [Progress in emergency medicine and cardiovascular imaging methods: RI imaging--single photon emission CT and positron emission tomography]. Hamanaka D; Ishii Y; Maeda H; Odori T; Hayakawa K; Asada N; Nakatsugawa S; Shibata T; Yamashita K; Okumura R Nihon Rinsho; 1986 Jun; 44(6):1308-15. PubMed ID: 3020272 [No Abstract] [Full Text] [Related] [Next] [New Search]